Telomerase gene therapy: a remission toward cancer.

Quazi S

DOI: 10.1007/s12032-022-01702-2
Published: 2022 Apr 16
Container: Medical oncology (Northwood, London, England)
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12032-022-01702-2,
  title = {Telomerase gene therapy: a remission toward cancer.},
  author = {Quazi S},
  year = {2022},
  journal = {Medical oncology (Northwood, London, England)},
  doi = {10.1007/s12032-022-01702-2},
  url = {https://doi.org/10.1007/s12032-022-01702-2}
}

RIS

TY  - JOUR
TI  - Telomerase gene therapy: a remission toward cancer.
AU  - Quazi S
PY  - 2022
JO  - Medical oncology (Northwood, London, England)
DO  - 10.1007/s12032-022-01702-2
UR  - https://doi.org/10.1007/s12032-022-01702-2
ER  -

APA

S, Q. (2022). Telomerase gene therapy: a remission toward cancer.. Medical oncology (Northwood, London, England). https://doi.org/10.1007/s12032-022-01702-2

Source records

pubmed · retrieved 2026-09-25T03:31:24.581Z